CIBC Private Wealth Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

CIBC Private Wealth Group’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$30.3K	Buy	52 +1	+2%	+$511	﹤0.01%	2001
2025 Q3	$23.4K	Buy	+51	New	+$19K	﹤0.01%	2101
2025 Q2	–	Sell	-14	Closed	-$4.24K	–	3224
2025 Q1	$4.24K	Sell	14 -1,036	-99%	-$340K	﹤0.01%	2492
2024 Q4	$350K	Sell	1,050 -2,050	-66%	-$577K	﹤0.01%	970
2024 Q3	$658K	Sell	3,100 -26,951	-90%	-$6.89M	﹤0.01%	788
2024 Q2	$8.74M	Buy	30,051 +1	+0%	+$238	0.02%	339
2024 Q1	$7.68M	Buy	+30,050	New	+$7.08M	0.02%	357

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's MDGL Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Madrigal Pharmaceuticals (MDGL) stake by 2% in Q4 2025, buying an estimated $511 and bringing the position to 52 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

CIBC Private Wealth Group first reported a position in MDGL in Q1 2024 and has held it in 7 quarters since. The position peaked at $8.74M in Q2 2024. 387 funds tracked by Wall St. Rank hold MDGL as of Q4 2025.

CIBC Private Wealth Group held 52 shares of Madrigal Pharmaceuticals worth $30.3K as of Q4 2025.
CIBC Private Wealth Group bought 1 Madrigal Pharmaceuticals share in Q4 2025, an estimated $511.
Madrigal Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2001 holding.
CIBC Private Wealth Group first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
CIBC Private Wealth Group's Madrigal Pharmaceuticals position peaked at $8.74M in Q2 2024.
387 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.